APA (7th ed.) Citation

Panda, A., Mehnert, J. M., Hirshfield, K. M., Riedlinger, G., Damare, S., Saunders, T., . . . Ganesan, S. (2018). Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer. JNCI : Journal of the National Cancer Institute, 110(3), 316-320. https://doi.org/10.1093/jnci/djx213

Chicago Style (17th ed.) Citation

Panda, Anshuman, et al. "Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." JNCI : Journal of the National Cancer Institute 110, no. 3 (2018): 316-320. https://doi.org/10.1093/jnci/djx213.

MLA (9th ed.) Citation

Panda, Anshuman, et al. "Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." JNCI : Journal of the National Cancer Institute, vol. 110, no. 3, 2018, pp. 316-320, https://doi.org/10.1093/jnci/djx213.